During the past decade, Silkeborg Regional Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 8 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 6 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Silkeborg Regional Hospital" #1 sponsor was "University of Aarhus" with 12 trials, followed by "Central Jutland Regional Hospital" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Odense University Hospital" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Silkeborg Regional Hospital" #1 collaborator was "Regionshospitalet Silkeborg" with 7 trials as a collaborator, "Aalborg University Hospital" with 3 trials as a collaborator, "Aarhus University Hospital" with 3 trials as a collaborator, "Association of Danish Physiotherapists" with 2 trials as a collaborator and "Danish Heart Foundation" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Silkeborg Regional Hospital" are "Crohn Disease" (4 trials), "Crohn's Disease" (4 trials), "Angina Pectoris" (2 trials), "Atrial Fibrillation" (2 trials) and "Cardiac Disease" (2 trials). Many other conditions were trialed in "Silkeborg Regional Hospital" in a lesser frequency.

Most popular intervention types in "Silkeborg Regional Hospital" are "Drug" (24 trials), "Other" (17 trials), "Procedure" (7 trials), "Diagnostic Test" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "GED-0301" (3 trials), "Exercise-group" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Silkeborg Regional Hospital" are 46 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Silkeborg Regional Hospital". 1 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Silkeborg Regional Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Silkeborg Regional Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 15 trials that are defined as “Not Applicable".